Clinical Trials Directory

Trials / Completed

CompletedNCT01138943

Chlorhexidine Mouthrinses and Plaque Control

Chlorhexidine Alcohol Base Mouthrinse Versus Chlorhexidine Formaldehyde Base Mouthrinse Efficacy on Plaque Control: Double Blind, Randomized Clinical Trials

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Hôpital Militaire De Rabat · Academic / Other
Sex
All
Age
20 Years – 25 Years
Healthy volunteers
Accepted

Summary

The aim of the present study was to compare antiplaque effectiveness of two commercial mouthrinses: 0.12 % Chlorhexidine alcohol base (CLX-A) versus a diluted 0.1% Chlorhexidine non-alcohol base with 0.1% of Formaldehyde (CLX-F).

Detailed description

Chlorhexidine (CLX) mouthrinse has been the gold standard as antiplaque solution.However, if its efficiency seems to be preserved even if the chlorhexidine concentration is bellow 0.10%, the formulation of the final product may affect the effectiveness. Thus, it can be concluded from this study that 0.12% CLX alcohol base mouthrinse is significantly more effective in inhibiting plaque than the diluted 0.1% CLX non-alcohol base containing formaldehyde mouthrinse.

Conditions

Interventions

TypeNameDescription
DRUGSynthodont15 ml, tree times/day for 07 days Arm: Chlorhexidine alcohol-base mouthrinse
DRUGSoludent15ml of 01% Chlorhexidine non alcohol-based, 3 times a day for 7 days Arm: Experimental: non alcohol chlorhexidine mouthrinse

Timeline

Start date
2007-02-01
Primary completion
2007-03-01
Completion
2007-04-01
First posted
2010-06-08
Last updated
2011-05-16

Locations

1 site across 1 country: Morocco

Source: ClinicalTrials.gov record NCT01138943. Inclusion in this directory is not an endorsement.